Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Regulatory issues in human gene therapy.

Kenneth Cornetta1

  • 1Department of Medical and Molecular Genetics, Indiana University School of Medicine, 975 W. Walnut Street, Indianapolis, IN 46202, USA. kcornett@iupui.edu

Blood Cells, Molecules & Diseases
|July 10, 2003
PubMed
Summary

Protecting human subjects in clinical trials is crucial. This review examines oversight agencies and evolving regulations impacting human gene therapy investigations, especially after past incidents intensified scrutiny.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.

Blood advances·2026
Same author

Development of a Novel Method to Detect AAV Vector Integration.

Viruses·2026
Same author

Promoting primary palliative care in Western Kenya using Project ECHO®.

African journal of primary health care & family medicine·2025
Same author

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.

The New England journal of medicine·2025
Same author

Modeling integration site data for safety assessment with MELISSA.

Nature communications·2025
Same author

Bioinformatic Analysis of the Genetic Basis of Differential Adeno-Associated Virus Production Capability of 293 Variants.

Human gene therapy·2025

Area of Science:

  • Bioethics
  • Clinical Trials
  • Gene Therapy Regulations

Background:

  • Investigator responsibility for human subject protection in clinical trials.
  • Public concerns regarding recombinant DNA technology led to unique oversight for gene therapy.
  • Past fatalities intensified regulatory oversight for gene therapy and other clinical research.

Purpose of the Study:

  • Review current oversight agencies for clinical trials.
  • Identify evolving regulations impacting gene therapy investigations.
  • Analyze challenges posed by new regulations to gene therapy researchers.

Main Methods:

  • Literature review of regulations and oversight bodies.
  • Analysis of historical events impacting clinical trial oversight.
Keywords:
Biomedical and Behavioral ResearchGenetics and ReproductionLegal Approach

Related Experiment Videos

  • Identification of current regulatory trends in gene therapy.

    • Main Results:

    • Overview of key agencies overseeing clinical trials.
    • Identification of specific regulatory changes post-1990s incidents.
    • Summary of challenges for gene therapy investigators.

    Conclusions:

    • Gene therapy research requires adherence to stringent ethical and legal standards.
    • Evolving regulations necessitate continuous adaptation by investigators.
    • Understanding oversight is critical for the future of gene therapy clinical trials.